Clinical Trial Update: Antiarrhythmic Effects of N-3 Fatty Acids [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating whether N-3 fatty acids (omega-3 fatty acids) have antiarrhythmic effects in patients with arrhythmias, including ventricular tachycard…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Arrhythmia
• Heart Disease
• Ventricular Fibrillation
• Ventricular Tachycardia

Drugs mentioned

• Omega-3 fatty acids (omega-3 fatty acids)

Snippet

Sponsor: National Heart, Lung, and Blood Institute (NHLBI) | Conditions: Arrhythmia, Heart Diseases | Phase 2 | Status: COMPLETED